Skip to main content
Andrew Artz, MD, Oncology, Duarte, CA, City of Hope Comprehensive Cancer Center

AndrewSaulArtzMDMS

Oncology Duarte, CA

Hematologic Oncology

Professor of Hematology and Hematopoietic Cell Transplantation City of Hope

Dr. Artz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Artz's full profile

Already have an account?

  • Office

    Division of Leukemia
    1500 East Duarte Road
    Duarte, CA 91010
    Phone+1 626-256-4673
    Fax+1 626-389-3060
  • Is this information wrong?

Summary

  • Dr. Andrew Artz is a hematologist/oncologist affiliated with City of Hope Medical Center in Duarte, CA. He received his medical degree from West Virginia University School of Medicine, medicine training at Georgetown University, and Hematology/Oncology fellowship at the University of Chicago. He specializes in treating blood cancers through the use of stem cell transplantation. Dr. Artz is the Director of the Program for Aging and Blood Cancers at City of Hope.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 2001 - 2004
  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1997 - 2000
  • West Virginia University School of Medicine
    West Virginia University School of MedicineClass of 1997

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2000 - 2026
  • CA State Medical License
    CA State Medical License 2019 - 2025
  • VA State Medical License
    VA State Medical License 1998 - 2002
  • DC State Medical License
    DC State Medical License 1999 - 2002
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Feasibility and Outcomes of T-Cell Depleted Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML and High Risk MDS
    Andrew S. Artz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A...
    Andrew S. Artz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Outcomes of IDH-Mutated Advanced Phase Ph-Negative Myeloproliferative Neoplasms Treated with IDH Inhibitors
    Andrew S. Artz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Adult and Pediatric BMT 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies in Acute Myeloid Leukemia (AML) Patients 60-75 Years of Age in First Complete R... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • City of Hope Researchers Present Innovative Studies at American Society of Hematology (ASH) Annual Meeting
    City of Hope Researchers Present Innovative Studies at American Society of Hematology (ASH) Annual MeetingDecember 13th, 2022
  • City of Hope Doctors Present New Research on Cancer Immunotherapies
    City of Hope Doctors Present New Research on Cancer ImmunotherapiesNovember 4th, 2021
  • Sydnexis Raises $45M in Series B Funding
    Sydnexis Raises $45M in Series B FundingAugust 11th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations